GALVECTA PLUS 50MG 850MG TAB 14S

Galvecta Plus 50mg/850mg Tablet 14s – Dual Therapy for Type 2 Diabetes Control

Overview: Galvecta Plus Tablet contains a combination of Vildagliptin (50mg) and Metformin HCl (850mg). It is an oral antidiabetic medication used to manage type 2 diabetes mellitus by improving glycemic control when diet and exercise alone are insufficient. The combination works by regulating insulin release and reducing hepatic glucose production.

Key Benefits:

• Dual-action formula with DPP-4 inhibitor (Vildagliptin) and Biguanide (Metformin)

• Helps lower HbA1c, fasting blood glucose, and post-meal sugar spikes

• Supports weight-neutral diabetes management

• Low risk of hypoglycemia when used alone

Indications:

• Adults with type 2 diabetes mellitus not adequately controlled by Metformin monotherapy

• Especially suitable for patients who prefer combination therapy in a single tablet

Dosage:

• Usually taken twice daily, with meals to reduce gastrointestinal side effects

• Dosage individualized based on clinical response

Precautions:

• Not for type 1 diabetes or diabetic ketoacidosis

• Regular monitoring of kidney function is essential

• Common side effects may include nausea, diarrhea, and headache

Packaging:

• Pack of 14 tablets, usually in a blister strip

• For prescription use only

SEO Meta Description (under 160 characters): Galvecta Plus 50mg/850mg Tablet combines Vildagliptin & Metformin to manage type 2 diabetes, improve blood sugar control, and support weight neutrality.